The potential importance of CD4+ TH17 cells in patients with multiple myeloma is an area of considerable interest and an increase in the frequency of such cells within the bone marrow has been reported [10, 13, 24, 25]. This evidence concerns the gene CD4 and plasma cell myeloma.